-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, OwF2bhA7DtCOe//tGUKb0JOYUC/l7w5sg2djp32gY0QzFlAxRrjdCl53YVm2MIuh zcetpPQqyWVnbvQwuszozQ== 0000000000-10-028745.txt : 20100708 0000000000-10-028745.hdr.sgml : 20100708 20100524181836 ACCESSION NUMBER: 0000000000-10-028745 CONFORMED SUBMISSION TYPE: UPLOAD PUBLIC DOCUMENT COUNT: 1 FILED AS OF DATE: 20100524 FILED FOR: COMPANY DATA: COMPANY CONFORMED NAME: MYRIAD GENETICS INC CENTRAL INDEX KEY: 0000899923 STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835] IRS NUMBER: 870494517 STATE OF INCORPORATION: DE FISCAL YEAR END: 0630 FILING VALUES: FORM TYPE: UPLOAD BUSINESS ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 MAIL ADDRESS: STREET 1: 320 WAKARA WAY CITY: SALT LAKE CITY STATE: UT ZIP: 84108 PUBLIC REFERENCE ACCESSION NUMBER: 0001193125-09-181226 LETTER 1 filename1.pdf begin 644 filename1.pdf M)5!$1BTQ+C4-"B6UM;6U#0HQ(#`@;V)J#0H\/"]4>7!E+T-A=&%L;V7!E+U!A9V5S+T-O=6YT(#$O2VED%L@,"`P(#8Q,B`W.3)=("]#;VYT96YTWY;/WX_7SV M^W%Q_KGZ63=55Z^;-V_8VZM+]G9V>G+^3C`AV6QY>B)8!C^"E1G/I&:YUKRT M;+8Z/GER#6'8]O63L_#,J,[W\<,4R M;T])[9F57/9;,MR%O2Q8[`D^D&9+PU7AQ+T@1`:$%(*;*"$J(,3F/(\2H@-" MC.)EE!`3$*(S+J*$V(`0:9\-.ZWJ!_9E3]+^`B$EU])?T)%8@T;RL.M'IBFX MMB-X+C,*;36WUD*R6/,LCL7D1C=5"QV-- M%H\M+!=QT"'@A#R>A'[\6.>V**R5\=A=.,1@AW"(PN["(08[A$,4=A<.^]AI ME4YL\CN56<*D/F,R$U2F:.#@3-%;C8@BIXG"@.GB>*_PZH,BZH,I]#,%?JLK M]JZZ2W6RJ5=U.I')PX)5S9Q]A5?\"V?35"5`3I3Y9C8E8%>QLB2YV:@!-@WZRFA MK3&>X#B3,GFV:>]:I=GFZOR9LZ4"OJHN"%RI*2J!9U;F)#<7<8WA-,+R&WD$/ M:MU@NKQBI`V%BSQO"=V_9"/L%"+H=PL?=37'.&?OTYY^FRP#M2_[SVA^^1W9ZLW=U@FJP?V-WY1.>PU\H!S MVWQ8,>\Y@V!^8"MH^;RM/VYQ1?.THZ(LIXSF^8'>0"A`^#(CUT#78'-_34EA M@1L.L>1!BCR('0==&0@Z98\SR[&@V\?VCGGP37^Q_;G%,-QT3%KLBC/JP%)! M$U#2VX^O%`+=G98*._2X0^QC#P[!_@3MXR`1L8'D]0O1U@J6:6PO#A00EJK,8/DP9HCK;;4.<\$;<:Q,T0*NF@9FY/,"V%!92H#S0ANX# M(5$.P5,@0IO04PLPN#E8\FH4#*/K2@$#%^2)MRQL=1T5#,H67,2YT<2Y$3C9 MO%POW25&'+:_Q/"PKAMVW'"/0=*/9M@3K%>/3[S1+>9LO6VA;7`URPU/^/Y7 MO?@7\>LEVPTET/0#D&1V`RE?^@I<-,T6!]4'=H.#F".DQW7;L77#WD&_#H53 M)2NZYFOP(T;DODR*1O`BJ3PP[">&0]5RC:'VPJV2TAG/AW7=_0+T*[!VXS`$ MI1M-X\JW2[9K-_$-[^;L"K<9!F'\O?JQ<.,<%&ZHM`H++=DEE]#7Y/[^9,M6 MVA%V-WV"A\&XO8N;-5MN8=<6SH%W`PQ]VOM]-;B]Z3:LPL:D8VY:N:\W^`#- MY1.$$UJ83#A+4QJ/SN(E26)=X"Q4@Y MUI7L[MID89XCT,V$=7.'1.WF?,@[F`A=,IU1F02F@8[%=I9'1H(#$W-3,O1F]N=%=E M:6=H="`W,#`O6$AE:6=H="`R-3`O3&5A9&EN9R`T,B]3=&5M5B`T,2]&;VYT M0D)O>%L@+34T-R`M,C$V(#$R,#8@-C7!E+T9O;G0O4W5B='EP92]4%=I9'1H(#(U-C@O M1F]N=%=E:6=H="`T,#`O6$AE:6=H="`R-3`O3&5A9&EN9R`T,B]3=&5M5B`T M,"]&;VYT0D)O>%L@+34V."`M,C$V(#(P,#`@-CDS72`^/@T*96YD;V)J#0HY M(#`@;V)J#0H\/"]4>7!E+T9O;G0O4W5B='EP92]47!E+T9O M;G0O4W5B='EP92]47!E+T9O M;G1$97-C%=I9'1H(#(U-3@O M1F]N=%=E:6=H="`W,#`O6$AE:6=H="`R-3`O3&5A9&EN9R`T,B]3=&5M5B`T M,B]&;VYT0D)O>%L@+34U."`M,C$V(#(P,#`@-C7,I+T-R96%T;W(H_O\`30!I`&,`<@!O`',`;P!F`'0`K@`@`$\`9@!F`&D` M8P!E`"``5P!O`'(`9``@`#(`,``P`#)SME]]`#C=*%;!DM4*&K30@A!HW,J7F1F;4.B).'1M!JA=$*O6.2,.NL8QU M5)P"&V*>"SFC`N,X%=>&;1`+-@T<"SK=41OZ"['BL%Y1"^:#IQWSP3,2U*WXH&18.B0=&@ M:%`T*!H4#8H&18-B0;&@6%`L*!84"XH%Q8)B0;&@>%`\*!X4#XH'Q8/B0?&@ M>%!\HSS1;N[Q_769SNOE[7E]O"S+P\O+.IV^79:?6W/
Z!Q(#("1F81G$@040`S`$@W#A%G[\@@]^9-GRX1,Q ME::6Z161+R>X*=9=*5X4YZBX!\6SX:7X5R4X*Z6]4MZ)9,RS6%:PAB7\=AMS M&6[_DP49R$(.;,A#`8K@@`L>^!!`"')E9@T*-S0T-@T*)25%3T8_ ` end -----END PRIVACY-ENHANCED MESSAGE-----